Cargando…
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality globally. Given the limited therapeutic efficacy in advanced HCC, prevention of HCC carcinogenesis could serve as an effective strategy. Patients with chronic fibrosis due to viral or metabolic etiologies are at a high...
Autores principales: | Li, Shen, Saviano, Antonio, Erstad, Derek J., Hoshida, Yujin, Fuchs, Bryan C., Baumert, Thomas, Tanabe, Kenneth K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760293/ https://www.ncbi.nlm.nih.gov/pubmed/33255794 http://dx.doi.org/10.3390/jcm9123817 |
Ejemplares similares
-
The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017) -
Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
por: Li, Shen, et al.
Publicado: (2018) -
Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017) -
Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019) -
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)